Outcome of patients with curative-intent treatment for primary pulmonary sarcoma: Results from an international multicenter retrospective study
Year: 2025
Type: article
Study design: Observational Study
Abstract: Objective: To evaluate outcome and prognostic factors of patients with primary pulmonary sarcoma (PPS) who underwent curative-intent surgery within multimodality treatment. Methods: An international, multicenter, retrospective study including patients with PPS was performed through a network of sarcoma experts. Data on demographics, staging, treatment, and outcomes were retrieved. Overall survival was calculated from the date of diagnosis. Prognostic factors were assessed using uni- and multivariate analysis. Results: = . 008) were independent prognostic factors for poor survival. Conclusions: In patients with curative-intent multimodal treatment for PPS, an encouraging 5-year survival rate of 49% can be achieved in expert centers. Independent prognostic factors may aid in selecting patients for curative treatment.
Source: JTCVS Open
Authors: Stephane Collaud, Theresa Stork, Dagmar Adamkova, Clemens Aigner, Ivan Bravio, Antonella Brunello, Luigi Cerbone, Hugo Clermidy, Lore De Cock, Silvia Gasperoni, Nicolas Girard, Anna Mariuk-Jarema, Rolf Lefering, Enrico Melis, Gloria Marquina, Filomena Mazzeo, Iurii Mykoliuk, Maria A. Pantaleo, Nicolas Penel, Hans-Ulrich Schildhaus, Sabino Strippoli, Bruno Vincenzi, Sarah Watson, Jean-Yves Blay, Sebastian Bauer
Institutions: Witten/Herdecke University, Kliniken der Stadt Köln, Masaryk University, Masaryk Memorial Cancer Institute, Medical University of Vienna, Instituto Português de Oncologia Francisco Gentil, Istituto Oncologico Veneto, Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo, Hospices Civils de Lyon, Hôpital Louis Pradel, Universitair Ziekenhuis Leuven, KU Leuven, Azienda Ospedaliero-Universitaria Careggi, Institut Curie, The Maria Sklodowska-Curie National Research Institute of Oncology, Instituto Nazionale Tumori Regina Elena, Universidad Complutense de Madrid, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Cliniques Universitaires Saint-Luc, UCLouvain, Medical University of Graz, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, Université de Lille, Centre Oscar Lambret, Istituto Tumori Bari, Università Campus Bio-Medico, Campus Bio Medico University Hospital, Centre National de la Recherche Scientifique, Inserm, Chimie et Biologie de la Cellule, Centre Léon Bérard, Essen University Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,431
OpenAlex ID: W4414572008